FI97690B - Lääkkeen vapautumista kontrolloiva koostumus - Google Patents

Lääkkeen vapautumista kontrolloiva koostumus

Info

Publication number
FI97690B
FI97690B FI901195A FI901195A FI97690B FI 97690 B FI97690 B FI 97690B FI 901195 A FI901195 A FI 901195A FI 901195 A FI901195 A FI 901195A FI 97690 B FI97690 B FI 97690B
Authority
FI
Finland
Prior art keywords
drug
coating material
long acting
drug release
composition
Prior art date
Application number
FI901195A
Other languages
English (en)
Swedish (sv)
Other versions
FI97690C (fi
FI901195A0 (fi
Inventor
Tadayoshi Ohmura
Muneo Fukui
Hiroshi Sugiura
Satoru Yoneya
Toshiharu Hosono
Atsushi Kajiyama
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Priority to FI951606A priority Critical patent/FI951606L/fi
Publication of FI901195A0 publication Critical patent/FI901195A0/fi
Application granted granted Critical
Publication of FI97690B publication Critical patent/FI97690B/fi
Publication of FI97690C publication Critical patent/FI97690C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Paints Or Removers (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI901195A 1989-03-10 1990-03-09 Lääkkeen vapautumista kontrolloiva koostumus FI97690C (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI951606A FI951606L (fi) 1989-03-10 1990-03-09 Keksinnön kohteena on menetelmä valmistaa pitkäaikaisvaikutteista rakeista farmaseuttista valmistetta

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP5868489 1989-03-10
JP5868489 1989-03-10

Publications (3)

Publication Number Publication Date
FI901195A0 FI901195A0 (fi) 1990-03-09
FI97690B true FI97690B (fi) 1996-10-31
FI97690C FI97690C (fi) 1997-02-10

Family

ID=13091382

Family Applications (1)

Application Number Title Priority Date Filing Date
FI901195A FI97690C (fi) 1989-03-10 1990-03-09 Lääkkeen vapautumista kontrolloiva koostumus

Country Status (19)

Country Link
US (1) US5028664A (fi)
EP (1) EP0386967B1 (fi)
JP (1) JPH037238A (fi)
KR (1) KR0140985B1 (fi)
CN (1) CN1045524A (fi)
AT (1) ATE124864T1 (fi)
AU (1) AU623233B2 (fi)
CA (1) CA2011919A1 (fi)
DD (2) DD298205A5 (fi)
DE (1) DE69020758T2 (fi)
DK (1) DK0386967T3 (fi)
ES (1) ES2077023T3 (fi)
FI (1) FI97690C (fi)
GR (1) GR3017645T3 (fi)
HU (1) HU204201B (fi)
IE (1) IE68520B1 (fi)
NO (1) NO301578B1 (fi)
NZ (1) NZ232836A (fi)
PT (1) PT93384B (fi)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GEP19971086B (en) * 1991-02-22 1997-12-02 Tillotts Pharma Ag Peroral Pharmaceutically Dispensed Form for Selective Introducing of the Medicine into the Intestine
GB9200607D0 (en) * 1992-01-13 1992-03-11 Ethical Pharma Ltd Pharmaceutical compositions containing nifedipine and process for the preparation thereof
US20030170290A1 (en) * 1993-06-16 2003-09-11 Shug Austin L. Delayed release carnitine
WO1995005168A1 (en) * 1993-08-19 1995-02-23 Shug Austin L Delayed release carnitine
DE9414066U1 (de) * 1994-08-31 1994-11-03 Röhm GmbH & Co. KG, 64293 Darmstadt Überzugs- und Bindemittel für Arzneiformen sowie damit hergestellte Arzneiform
NZ270078A (en) * 1994-12-06 1998-05-27 Bernard Charles Sherman Diltiazem hydrochloride formulation comprising beads with immediate, intermediate, and delayed release dissolution profiles
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
US6254889B1 (en) * 1995-07-26 2001-07-03 Kyowa Hakko Kogyo Co., Ltd. Solid dispersion dosage form of amorphous xanthine derivative and enteric-coating polymer
US6162463A (en) * 1997-05-01 2000-12-19 Dov Pharmaceutical Inc Extended release formulation of diltiazem hydrochloride
US6342611B1 (en) * 1997-10-10 2002-01-29 Cytovia, Inc. Fluorogenic or fluorescent reporter molecules and their applications for whole-cell fluorescence screening assays for capsases and other enzymes and the use thereof
EP1053752A1 (en) 1998-02-10 2000-11-22 Yoshitomi Pharmaceutical Industries, Ltd. Preparations with controlled release
ATE367153T1 (de) * 1999-05-20 2007-08-15 Elan Corp Plc Multipartikuläre arzneizusammensetzungen mit gesteuerter wirkstoffabgabe enthaltend selektive inhibitoren der serotoninwiederaufnahme
EP1064938A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Pharmaceutical dosage forms for controlled release producing at least a timed pulse
PT1207860E (pt) * 1999-09-02 2008-01-24 Nostrum Pharmaceuticals Inc Formulação de peletes de libertação controlada
AR026148A1 (es) * 2000-01-21 2003-01-29 Osmotica Argentina S A Dispositivo osmotico con pasaje preformado que aumenta de tamano
WO2002066004A1 (fr) * 2001-02-23 2002-08-29 Mitsubishi Pharma Corporation Compositions a liberation controlee de medicament
CA2466726C (en) * 2001-11-21 2011-02-22 Eisai Co., Ltd. Preparation composition containing acid-unstable physiologically active compound and process for producing same
SE0201110D0 (sv) * 2002-04-12 2002-04-12 Astrazeneca Ab New film coating
US20060246003A1 (en) * 2004-12-27 2006-11-02 Eisai Co. Ltd. Composition containing anti-dementia drug
US20090208579A1 (en) * 2004-12-27 2009-08-20 Eisai R & D Management Co., Ltd. Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
JP2008525313A (ja) 2004-12-27 2008-07-17 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗痴呆薬の安定化方法
CN100398122C (zh) * 2005-01-28 2008-07-02 北京北大药业有限公司 一种治疗颈、腰椎病中药的肠溶包衣组合物
BRPI0821985A2 (pt) * 2008-01-10 2015-06-23 Evonik Roehm Gmbh Preparacao farmacêutica ou nutracêutica revestida tendo liberação de substância ativa controlada
CN101903017B (zh) 2008-01-10 2014-12-24 赢创罗姆有限公司 具有增强的脉冲活性物质释放的包衣的药物或营养制剂
US9408393B2 (en) 2010-02-03 2016-08-09 Microbion Corporation Bismuth-thiols as antiseptics for agricultural, industrial and other uses
US9028878B2 (en) 2009-02-03 2015-05-12 Microbion Corporation Bismuth-thiols as antiseptics for biomedical uses, including treatment of bacterial biofilms and other uses
CN102341105B (zh) * 2009-02-03 2014-09-17 微生物公司 用作上皮组织、急性和慢性伤口、细菌生物被膜和其他适应症的抗菌剂的铋硫醇
CN112788950A (zh) 2018-07-31 2021-05-11 微生物公司 用于治疗伤口的铋-硫醇组合物和方法
WO2020028558A1 (en) 2018-07-31 2020-02-06 Microbion Corporation Bismuth-thiol compositions and methods of use
WO2022029938A1 (ja) * 2020-08-05 2022-02-10 マルホ株式会社 皮膚用組成物

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3236914A (en) * 1959-05-12 1966-02-22 Canadian Ind Method for rendering polymers compatible
US3300429A (en) * 1963-06-17 1967-01-24 Rohm & Haas Aqueous polymeric blends containing ureido monomer
US3369009A (en) * 1964-12-10 1968-02-13 Hercules Inc Azidoformate-containing copolymers
US3641237A (en) * 1970-09-30 1972-02-08 Nat Patent Dev Corp Zero order release constant elution rate drug dosage
US4065523A (en) * 1975-11-24 1977-12-27 Rohm And Haas Company Process for increasing molecular weight of a polymer
US4082705A (en) * 1976-02-05 1978-04-04 Johnson & Johnson Pressure sensitive adhesive compositions
GB2046275A (en) * 1979-03-27 1980-11-12 American Cyanamid Co Granulation and drying aids for polymeric gels
SE8003805L (sv) * 1980-05-21 1981-11-22 Haessle Ab En farmaceutisk beredning med forbettrade utlosningsegenskap
US4539199A (en) * 1981-01-14 1985-09-03 Egyt Gyogyszervegyeszeti Gyar Sustained release pharmaceutical compositions
US4758437A (en) * 1981-12-23 1988-07-19 Yamanouchi Pharmaceutical Co., Ltd. Composition for long acting nicardipine preparation and process of producing the composition
JPS6051106A (ja) * 1983-08-31 1985-03-22 Yamanouchi Pharmaceut Co Ltd 塩酸アモスラロ−ル持続性製剤
JPS60240747A (ja) * 1984-05-15 1985-11-29 Showa Denko Kk 架橋性組成物及びエステル架橋型重合体
JPS62126122A (ja) * 1985-11-27 1987-06-08 Showa Shinyaku Kk 表面コ−テイングされたイブプロフエン顆粒の製法
IL77186A0 (en) * 1985-11-29 1986-04-29 Touitou Elka Pharmaceutical insulin composition
JP2667162B2 (ja) * 1986-11-04 1997-10-27 日本製紙株式会社 インクジエツト記録用シート
SE460946B (sv) * 1987-03-16 1989-12-11 Lejus Medical Ab En multipel-unit-dos komposition av kinidinglukonat

Also Published As

Publication number Publication date
FI97690C (fi) 1997-02-10
KR900013943A (ko) 1990-10-22
AU5122790A (en) 1990-09-13
EP0386967A2 (en) 1990-09-12
NO901116D0 (no) 1990-03-09
GR3017645T3 (en) 1996-01-31
NZ232836A (en) 1991-06-25
DD298205A5 (de) 1992-02-13
PT93384B (pt) 1996-03-29
ES2077023T3 (es) 1995-11-16
EP0386967B1 (en) 1995-07-12
IE68520B1 (en) 1996-06-26
DE69020758T2 (de) 1995-12-07
NO301578B1 (no) 1997-11-17
US5028664A (en) 1991-07-02
DD292374A5 (de) 1991-08-01
ATE124864T1 (de) 1995-07-15
HU901380D0 (en) 1990-05-28
KR0140985B1 (ko) 1998-06-01
FI901195A0 (fi) 1990-03-09
CA2011919A1 (en) 1990-09-10
IE900862L (en) 1990-09-10
DK0386967T3 (da) 1995-11-20
CN1045524A (zh) 1990-09-26
AU623233B2 (en) 1992-05-07
HUT53813A (en) 1990-12-28
JPH037238A (ja) 1991-01-14
DE69020758D1 (de) 1995-08-17
HU204201B (en) 1991-12-30
EP0386967A3 (en) 1991-04-03
PT93384A (pt) 1990-11-07
NO901116L (no) 1990-09-11

Similar Documents

Publication Publication Date Title
FI97690B (fi) Lääkkeen vapautumista kontrolloiva koostumus
DE59202537D1 (de) Feste pharmazeutische Retardform.
ES2094359T3 (es) Formulaciones farmaceuticas de proteinas osteogenicas.
ATE222487T1 (de) Brausemittel und dessen herstellung
ES2080796T5 (es) Formulaciones de productos farmaceuticos de liberacion prolongada.
DK0868910T3 (da) Anvendelse af redispergerbare polymerpulvere eller polymergranulater som bindemidler til fremstilling af faste farmaceutiske dispergeringsformer
ATE345781T1 (de) Drei verschiedene polymertypen enthaltende formulierung mit verzögerter freigabe
CA2037101A1 (en) Omeprazole Compositions Designed for Administration in Rectum
CA2312710A1 (en) Sustained release formulation containing three different types of polymers and tablet formed therefrom
ZA921875B (en) New esters of bi- and tricyclic amino alcohols, their preparation and their use in pharmaceutical compositions
CA2225286A1 (en) A composition comprising an active agent dissolved in a glass-forming carrier and a process for the preparation thereof
CA2126091A1 (fr) Nouveaux polypeptides biologiquement actifs, leur preparation et composition pharmaceutique les contenant
DK0923934T3 (da) Modified release-matrixformulering af cefaclor og cephalexin
DE69306212D1 (de) Kardioaktive 17-aryl und 17-heterozyklyl-14 beta-5alpha-Androstane, Androstene und Androstadiene, ein Verfahren zu ihrer Herstellung und pharmazeutische Präperate davon
DE69901487D1 (de) Eine didemnin verbindung enthaltende pharmazeutische formulierung
AU7125991A (en) Novel antiulcer substance
ATE85213T1 (de) Einen wirkstoff und ein in wasser quellendes polymer enthaltendes arzneimittel.
AU4737989A (en) Benzene derivatives, their preparation and pharmaceutical compositions in which they are present
DE69602886D1 (de) Im kardiovaskulären System aktive seco-D-Steroide und diese enthaltende pharmazeutische Zubereitungen
DE68902811D1 (de) Pharmazeutische zusammensetzungen mit einem gehalt an labdan-di-terpenoid-derivaten und pyrimido(6,1-a)isochinolin-4-on-derivaten und ihre anwendung.
DE69016592D1 (de) 4-Amidino-Chroman und 4-Amidino-Pyrano(3,2-c)pyridinderivate, Verfahren zur Herstellung und diese enthaltende pharmazeutische Zusammenstellungen.
GEP20012518B (en) Novel Erythromycin Derivatives, Method for Their Preparation and Their Use as Medicine
SI1484033T1 (sl) Tekoäśi polimerni sestavki za nadzorovano sproĺ äśanje bioaktivnih substanc
DE3787319D1 (de) 1,4-Dihydropyridin-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen.
AU5766790A (en) Liquid polymer composition, and method of use

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: YAMANOUCHI PHARMACEUTICAL CO., LTD.